ICICI Securities
ISEC NSE
ICICI Securities
Financial ServicesNSE: ISEC Capital Markets
Tapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Strengths
4- Company has a good return on equity (ROE) track record: 3 Years ROE 38.5%
- Company has been maintaining a healthy dividend payout of 36.1%
- Debtor days have improved from 47.5 to 33.6 days.
- Company's median sales growth is 25.1% of last 10 years
Weaknesses
1- Company might be capitalizing the interest cost
Growth Rate
Revenue Growth
-1% lower than
3Y
Net Income Growth
-4% lower than
3Y
Quarterly Results
| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 934 | 1,249 | 1,323 | 1,543 | 1,641 | 1,707 | 1,586 | 1,398 | 1,409 | 1,422 | 1,555 | 1,503 | 1,547 |
| Expenses | 363 | 439 | 412 | 464 | 506 | 539 | 417 | 412 | 440 | 405 | 432 | 438 | 441 |
| Operating Profit | 571 | 810 | 911 | 1,079 | 1,135 | 1,168 | 1,169 | 986 | 969 | 1,017 | 1,123 | 1,065 | 1,106 |
| OPM % | 61% | 65% | 69% | 70% | 69% | 68% | 74% | 71% | 69% | 72% | 72% | 71% | 71% |
| Other Income | 0 | 0 | 1 | 1 | 3 | 0 | 0 | -1 | 2 | 1 | 1 | 1 | 1 |
| Interest | 185 | 215 | 261 | 327 | 394 | 419 | 454 | 433 | 406 | 406 | 448 | 463 | 502 |
| Depreciation | 22 | 26 | 27 | 34 | 37 | 39 | 39 | 43 | 40 | 41 | 40 | 40 | 42 |
| PBT | 364 | 569 | 624 | 720 | 708 | 711 | 676 | 510 | 526 | 572 | 637 | 564 | 563 |
| Tax % | 26% | 26% | 25% | 25% | 26% | 26% | 25% | 25% | 26% | 26% | 25% | 25% | 26% |
| Net Profit | 271 | 424 | 466 | 537 | 527 | 529 | 504 | 381 | 391 | 425 | 475 | 422 | 419 |
| EPS in Rs | 8.39 | 13.11 | 14.41 | 16.59 | 16.28 | 16.33 | 15.52 | 11.72 | 12.03 | 13.07 | 14.59 | 12.99 | 12.88 |
Profit & Loss
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,210 | 1,125 | 1,403 | 1,861 | 1,725 | 1,721 | 2,586 | 3,435 | 3,422 | 5,049 | 6,335 | 5,890 | 6,028 |
| Expenses | 711 | 707 | 838 | 942 | 912 | 823 | 993 | 1,250 | 1,313 | 1,678 | 1,860 | 1,715 | 1,716 |
| Operating Profit | 499 | 417 | 566 | 919 | 813 | 898 | 1,593 | 2,185 | 2,109 | 3,372 | 4,475 | 4,174 | 4,311 |
| OPM % | 41% | 37% | 40% | 49% | 47% | 52% | 62% | 64% | 62% | 67% | 71% | 71% | 72% |
| Other Income | -2 | -1 | 1 | -2 | 1 | 3 | -1 | 4 | 4 | 2 | -14 | 6 | 5 |
| Interest | 31 | 26 | 29 | 50 | 42 | 86 | 107 | 274 | 536 | 987 | 1,699 | 1,723 | 1,820 |
| Depreciation | 16 | 16 | 15 | 15 | 15 | 61 | 54 | 63 | 75 | 109 | 157 | 160 | 162 |
| PBT | 450 | 374 | 522 | 852 | 757 | 753 | 1,431 | 1,853 | 1,501 | 2,278 | 2,605 | 2,297 | 2,335 |
| Tax % | 35% | 36% | 35% | 35% | 35% | 28% | 25% | 25% | 26% | 26% | 25% | 25% | — |
| Net Profit | 294 | 239 | 339 | 553 | 491 | 542 | 1,068 | 1,383 | 1,118 | 1,697 | 1,941 | 1,713 | 1,741 |
| EPS in Rs | 3.65 | 2.96 | 4.2 | 17.18 | 15.24 | 16.83 | 33.14 | 42.84 | 34.61 | 52.46 | 59.7 | 52.68 | 53.53 |
| Div. Payout % | 55% | 67% | 61% | 32% | 62% | 65% | 65% | 56% | 55% | 55% | 30% | 23% | — |
Balance Sheet
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 161 | 161 | 161 | 161 | 161 | 161 | 161 | 161 | 161 | 162 | 121 | 121 |
| Reserves | 191 | 237 | 329 | 687 | 886 | 1,048 | 1,661 | 2,269 | 2,691 | 3,761 | 5,301 | 6,174 |
| Borrowings | 227 | 173 | 395 | 677 | 452 | 1,657 | 3,630 | 7,846 | 9,408 | 16,887 | 21,083 | 25,258 |
| Other Liabilities | 784 | 826 | 1,162 | 1,349 | 3,165 | 1,576 | 2,729 | 3,370 | 3,308 | 4,814 | 3,543 | 3,828 |
| Total Liabilities | 1,363 | 1,397 | 2,047 | 2,874 | 4,665 | 4,443 | 8,181 | 13,646 | 15,569 | 25,623 | 30,048 | 35,380 |
| Fixed Assets | 35 | 35 | 35 | 38 | 44 | 198 | 161 | 184 | 258 | 529 | 663 | 618 |
| CWIP | 4 | 2 | 3 | 4 | 4 | 8 | 8 | 14 | 31 | 30 | 17 | 90 |
| Investments | 1 | 1 | 2 | 4 | 3 | 2 | 469 | 254 | 924 | 406 | 321 | 200 |
| Other Assets | 1,323 | 1,358 | 2,008 | 2,828 | 4,614 | 4,234 | 7,543 | 13,195 | 14,356 | 24,658 | 29,048 | 34,471 |
| Total Assets | 1,363 | 1,397 | 2,047 | 2,874 | 4,665 | 4,443 | 8,181 | 13,646 | 15,569 | 25,623 | 30,048 | 35,380 |
Cash Flow
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | — | — | 165 | 71 | 2,289 | -1,878 | -1,610 | -2,597 | -674 | -5,621 | -1,779 | -1,459 |
| Investing | — | — | -17 | -21 | -21 | -23 | -40 | -69 | -125 | -257 | -208 | -180 |
| Financing | — | — | -54 | 6 | -561 | 559 | 1,417 | 3,130 | 266 | 5,715 | 1,972 | 1,607 |
| Net Cash Flow | — | — | 94 | 56 | 1,707 | -1,342 | -233 | 464 | -533 | -163 | -15 | -32 |
| Free Cash Flow | — | — | 150 | 49 | 2,268 | -1,901 | -1,650 | -2,661 | -799 | -5,878 | -1,987 | -1,639 |
| CFO/OP | — | — | 64 | 43 | 315 | -186 | -80 | -98 | -14 | -152 | -25 | -21 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 52 | 95 | 185 | 61 | 101 | 19 | 65 | 41 | 83 | 69 | 40 | 34 |
| Cash Conversion Cycle | 52 | 95 | 185 | 61 | 101 | 19 | 65 | 41 | 83 | 69 | 40 | 34 |
| Working Capital Days | -194 | -73 | -154 | -284 | -555 | -399 | -285 | -286 | -235 | -244 | -135 | -150 |
| ROCE % | 84% | 70% | 76% | 75% | 53% | 38% | 37% | 27% | 18% | 20% | 18% | 14% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view ICICI Securities insights
56 extracted metrics + investor summaries across FY03–FY26.
Documents
1
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
17 Mar 2025 - We have allotted 99,779 equity shares of face value of Rs. 5/- each on March 17, 2025. 17 Mar 2025 - We have allotted 99,779 equity shares of face value of Rs. 5/- each on March 17, 2025.
3
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
10 Mar 2025 - We have allotted 2,888 equity shares of face value of Rs. 5/- each on March 10, 2025. 10 Mar 2025 - We have allotted 2,888 equity shares of face value of Rs. 5/- each on March 10, 2025.
4
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015
10 Mar 2025 - NCLAT dismisses appeals regarding Scheme of Arrangement. 10 Mar 2025 - NCLAT dismisses appeals regarding Scheme of Arrangement.
5
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
3 Mar 2025 - We have allotted 4,006 equity shares of face value of Rs. 5/- each on March 3, 2025. 3 Mar 2025 - We have allotted 4,006 equity shares of face value of Rs. 5/- each on March 3, 2025.
Frequently Asked Questions about ICICI Securities
What does ICICI Securities Ltd do?
ICICI Securities Limited is engaged in the business of broking (institutional and retail), distribution of financial products, merchant banking and advisory services. [1]
Where is ICICI Securities Ltd (ISEC) listed?
ICICI Securities Ltd trades as ISEC on the NSE.
Which sector does ICICI Securities Ltd belong to?
ICICI Securities Ltd is classified under the Financial Services sector, in the Capital Markets industry.
What is the PE ratio of ICICI Securities Ltd?
ICICI Securities Ltd trades at a PE ratio of 16.74.
Company Information
ICICI Securities Limited is engaged in the business of broking (institutional and retail), distribution of financial products, merchant banking and advisory services. [1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/ISEC.md for ICICI Securities Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.